Skip to main content

Island ENT

We are here to help...
Home
Dr. Carabin
Publications
Facts About Sleep Apnea
Sleep Quiz
Pilots and Truckers
Sleep Apnea Testing
Allergy Symptoms
Contact Us
Support group
 

 

PUBLICATIONS

Burdock GA, Carabin, IG, Crincoli C (2009). Safety assessment of Kola Nut extract as a food ingredient. Food and Chemical Toxicology. [Epub ahead of print].

Carabin, IC, Lyon MR, Wood, S, et al (2009). Supplementation of the diet with the functional fiber PolyGlycoplex® is well tolerated by healthy subjects in a clinical trial. Nutrition Journal. 2009 Feb 5;8(1):9. Doi: 10.1186/1475-2891-8-9.

Burdock GA and Carabin, IG (2008). Safety assessment of Coriander (Coriandrum sativum L.) essential oil as a food ingredient. Food and Chemical Toxicology. Doi: 10.1016/j.fct.2008.11.006.

Burdock GA and Carabin, IG (2008). Safety assessment of 2-ethyl-3,(5 or 6) dimethylpyrazine as a food ingredient. Regulatory Toxicology and Pharmacology, 50:303–312.

Dyer AR, Burdock GA, Carabin IG, Haas MC, Boyce J, Alsaker R, and Read LC. (2008) In vitro and in vivo safety studies on a proprietary whey extract. Food and Chemical Toxicology, 46: 1659–1665.

Burdock, GA and Carabin, IG (2008). Safety assessment of sandalwood oil (Santalum album L.).
Food and Chemical Toxicology, Feb 46(2):421-32.

Burdock, GA and Carabin, IG (2008) Safety assessment of ylang-ylang oil as a food ingredient.

Food and Chemical Toxicology, Feb 46(2):433-45.

Burdock, GA and Carabin, IG (2008). Breaking Down the Barriers to Functional Foods, Nutraceuticals and Claims. Book Chapter In: Nutraceutical and Functional Food Regulation in the United States and Around the World, a volume of the Food Science and Technology, International Series. Elsevier, Inc., NY, p. 83-108.

Burdock, GA and Carabin, IG (2007). Safety assessment of hydroxypropyl methylcellulose as a food ingredient. Food and Chemical Toxicology 45:2341-2351.

Carabin, IG and Griffiths, JC (2007). Functional Foods & Structure/Function Claims. Is There a Difference Between Sexes? Nutritional Outlook, June issue.

Burdock, GA and Carabin, IG (2007). Safety assessment of myristic acid as a food ingredient.
Food and Chemical Toxicology 45: 517-529.

Carabin, IG (2006). Functional foods for women’s health. Natural Products Industry Insider, August.

Burdock, GA, Carabin, IG and Griffiths, JC (2006). Toxicology and pharmacology of sodium ricinoleate. Food and Chemical Toxicology 44:1689-1698.

Carabin, IG and Casterton, P. (2006). Allergen labeling. Protecting the public. Asia Food Journal. May 2006.

Carabin, IG and Matulka, R. (2006). Proving efficacy. The World of Food Ingredients. April/May.

Carabin, IG and Magnuson, BA (2006). New Labeling Requirements for Food Allergens. Nutritional Outlook, April. http://www.nutritionaloutlook.com/article.php?ArticleID=2096

Burdock, GA, Carabin, IC and Griffiths, JC (2006). The Importance of GRAS to the Functional Foods and Nutraceutical Industries. Toxicology 221, p. 17-27.

Soni, MG, Carabin, IG and Burdock, GA (2005). Safety Assessment of Esters of p-Hydroxybenzoic Acid (Parabens). Food and Chemical Toxicology 43:985-1015.

Carabin, IG (2005). The Clinical Aspects of Claim Substantiation: The Concept of Cause and Effect. FDLI Update, Issue 2, p. 36-39.

Carabin, IG and Burdock, GA (2005). Obesity in the United States: An overview. FDLI Update, Issue 1, p. 9-14.

Carabin, IG (2004). The Role of Clinical Trials in Dietary Supplement Claim Substantiation. A Regulatory and Historical Perspective. ACRP Monitor, Vol. 18, Issue 4, p. 25-29.

Carabin, IG (2004). The Clinical Aspects of Claim Substantiation: Inclusion/Exclusion

Criteria, Screening and Baseline Evaluations in Clinical Trials. FDLI Update, Issue 5, p. 41-45.

Carabin, IG (2004). The Clinical Aspects of Claim Substantiation: Clinical Trial Costs. FDLI Update, Issue 4, p. 39-43.

Carabin, IG (2004). The Clinical Aspects of Claim Substantiation. FDLI Update, Issue 3,

p. 25-29.

Burdock, GA and Carabin, IG (2004). Warning Letters, Recalls and the “Elixir of Death.” FDA Regulation in Nutritional Outlook, March.

Soni, MG; Carabin, IG; Griffiths JC and Burdock GA (2004). Safety of Ephedra: Lessons Learned. Toxicol Lett. Apr 15; 150(1): 97-110.

Burdock, GA and Carabin, IG (2004). Generally Recognized As Safe (GRAS): History and Description. Toxicol Lett. Apr15: 150(1): 3-18.

Burdock, GA; Carabin, IG and Soni, MG (2001). Safety assessment of Beta-nitropropionic acid: A monograph in support of an acceptable daily intake in humans. Food Chemistry 75/1:1-27.

Burdock, GA; Soni, MG and Carabin, IG (2001). Evaluation of the Health Aspects of Kojic Acid in Food. Food and Chemical Toxicology 33:80-101.

Carabin, IG; Burdock, GA and Chatzidakis C (2000). Safety Assessment of Panax Ginseng. International Journal of Toxicology 19:293-301.

Burdock, GA; Flamm, WG and Carabin, IG (2000). Toxicity and Mutagenicity Studies of DN-50000® and RP-1® Enzymes. Food and Chemical Toxicology 38:429-442.

Carabin, IG and Flamm, WG (1999). Evaluation of the Safety of Inulin and Oligofructose as Dietary Fiber. Regulatory Toxicology and Pharmacology 30:268-282.

Lawson W, Carabin IG: Paranasal Sinus Surgery (1993) In Krespi YP, et al: Complications in Head and Neck Surgery, WB Saunders Co., p. 115-129.